# Late-Course Accelerated Hyperfractionated IMRT for Locoregionally Advanced Nasopharyngeal Carcinoma

> **NCT00778908** · PHASE2,PHASE3 · COMPLETED · sponsor: **Guangxi Medical University** · enrollment: 120 (actual)

## Conditions studied

- Nasopharyngeal Carcinoma

## Interventions

- **RADIATION:** Late-course accelerated hyperfractionated IMRT
- **DRUG:** Concomitant cisplatin chemotherapy
- **RADIATION:** Conventionally fractionated IMRT

## Key facts

- **NCT ID:** NCT00778908
- **Lead sponsor:** Guangxi Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2011-01
- **Final completion:** 2011-12
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2012-08-21

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00778908

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00778908, "Late-Course Accelerated Hyperfractionated IMRT for Locoregionally Advanced Nasopharyngeal Carcinoma". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00778908. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*